Highline Wealth Partners LLC Blueprint Medicines Corp Transaction History
Highline Wealth Partners LLC
- $297 Billion
- Q1 2025
A detailed history of Highline Wealth Partners LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Highline Wealth Partners LLC holds 42 shares of BPMC stock, worth $3,681. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42Holding current value
$3,681% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
384Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$594 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$583 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$498 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$219 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$170 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.24B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...